RedHill Biopharma secures $60m licensing agreement with Hyloris for global commercialization of RHB-102
RedHill Biopharma Ltd. has entered into an exclusive licensing agreement with Hyloris Pharmaceuticals SA, granting the Belgian company the rights to develop and commercialize RHB-102 ... Read More
RedHill Biopharma expands U.S. partnerships for opaganib manufacturing amid COVID-19 fight
Israeli biopharma company RedHill Biopharma has significantly advanced its efforts to combat COVID-19 by forging strategic partnerships with two U.S.-based manufacturers. These collaborations aim to ... Read More